Psoriasis management has traditionally focused on controlling skin symptoms, but these findings emphasise the need to consider the wider health risks faced by patients. He added that GLP-1RAs may offer a valuable dual benefit by improving metabolic control and long-term health outcomes, which he said represented an important step forward in holistic care for people living with psoriasis
Participants on the highest doses lost roughly 24% of their body weight over 48 weeks, a pace of reduction that exceeded most other GLP-1-based treatments
for instance, its easier to skip the gym or eat the familiar comfort food (and now one might justify it by Im on a weight-loss shot anyway)
They highlight that inadvertent intravascular injection, high cumulative dosing, and patient factors (extremes of age, cardiac, hepatic, or renal disease, pregnancy) are major contributors, and that bupivacaine carries the greatest cardiotoxic risk
Does that mean theyre illegal
holding the needle in place ~5 seconds before withdrawal